Epidemiology & Risk Factors

  • Lactational (Puerperal): Most common; typically occurs 2–6 weeks postpartum as a progression from untreated or inadequately treated lactational mastitis.
  • Non-lactational: Less common; associated with smoking, DM, nipple piercing, inverted nipples, or trauma.
  • Etiology:
    • Staphylococcus aureus (most common, including MRSA).
    • Streptococcus pyogenes, Pseudomonas, anaerobes (more common in non-lactating/subareolar abscesses).
  • Pathogenesis: Nipple fissuring/abrasion bacterial entry milk stasis mastitis localized focal parenchymal necrosis and pus collection.

Clinical Features

  • Symptoms:
    • Unilateral, severe focal breast pain, swelling, and localized tenderness.
    • Systemic symptoms: Fever, chills, malaise, body aches.
  • Physical Exam:
    • Painful, tender, erythematous breast mass.
    • Fluctuance (pathognomonic sign distinguishing abscess from uncomplicated mastitis).
    • Localized warmth, edema, skin induration.
    • Reactive axillary lymphadenopathy.

Diagnosis

  • Initial & Diagnostic Test of Choice (Imaging): Targeted Breast Ultrasound (US).
    • Findings: Hypoechoic/anechoic fluid collection with posterior acoustic enhancement, internal debris/septa, and hypervascular border.
    • Role: Confirms abscess and differentiates from simple mastitis (diffuse skin thickening/edema without fluid collection).
  • Key Labs:
    • CBC (leukocytosis with left shift).
    • Gram stain & culture of aspirated fluid (guides Abx de-escalation).
  • Biopsy:
    • Core needle biopsy or skin punch biopsy indicated if patient is non-lactating, post-menopausal, recurrent, or non-healing despite treatment to rule out inflammatory breast carcinoma (IBC).

Differential Diagnostics

  • Lactational Mastitis:
    • Diff: Diffuse erythema and tenderness without fluctuance; US shows parenchymal edema without fluid collection.
  • Galactocele:
    • Diff: Retention cyst due to occluded lactiferous duct; non-erythematous, painless or mildly tender, afebrile, aspiration yields milky fluid.
  • Inflammatory Breast Carcinoma (IBC):
    • Diff: Rapidly progressive erythema, edema, and peau d’orange appearance; non-responsive to Abx; no fluid collection on US; punch biopsy reveals dermal lymphatic invasion by tumor cells.
  • Simple Breast Cyst / Fibrocystic Changes:
    • Diff: Fluid collection on US, but afebrile, non-erythematous, lacking systemic inflammatory signs.

Management

  1. First-line Local Drainage Procedure:
    • Ultrasound-guided needle aspiration: Preferred initial intervention (better cosmetic result, lower morbidity).
    • Surgical Incision & Drainage (I&D): Indicated if large (> 5 cm), multiloculated, overlying skin ischemia/necrosis, or failed needle aspiration.
  2. Empiric Antibiotic Therapy (10–14 days course):
    • Low MRSA Risk (Outpatient/Mild): Dicloxacillin or Cephalexin PO.
    • High MRSA Risk / Community-Acquired MRSA: Trimethoprim-sulfamethoxazole (TMP-SMX) or Clindamycin PO.
      • Note: Avoid TMP-SMX in nursing mothers with infants < 1 month or with hyperbilirubinemia.
    • Severe / Inpatient Sepsis: IV Vancomycin.
  3. Lactation Management (High-Yield USMLE Concept):
    • Continue breastfeeding or pumping from BOTH breasts (including affected breast) every 2–3 hours to promote milk drainage and prevent stasis/re-accumulation.
    • Temporary cessation of breastfeeding on affected side (pump and dump) only if incision/wound directly interferes with latch or purulent discharge contacts infant’s mouth.
  4. Symptomatic Support: NSAIDs/acetaminophen for pain/fever; warm compresses.

Complications

  • Recurrence or non-healing abscess (warrants biopsy for malignancy).
  • Mammary duct fistula (subareolar abscesses in smokers).
  • Sepsis and systemic bacteremia.
  • Cosmetic deformity / tissue scarring.